Hongzan Ji

838 total citations
9 papers, 420 citations indexed

About

Hongzan Ji is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Hongzan Ji has authored 9 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Hongzan Ji's work include Microscopic Colitis (2 papers), Eosinophilic Esophagitis (2 papers) and RNA modifications and cancer (1 paper). Hongzan Ji is often cited by papers focused on Microscopic Colitis (2 papers), Eosinophilic Esophagitis (2 papers) and RNA modifications and cancer (1 paper). Hongzan Ji collaborates with scholars based in China, Finland and United States. Hongzan Ji's co-authors include Xiaobing Xu, Rongsheng Zhang, Xuan Wang, Bin Zhang, Lei Lü, Stina Syrjänen, Maarit Anttila, Seppo Saarikoski, Karí Syrjänen and Lin Wu and has published in prestigious journals such as Science Advances, World Journal of Gastroenterology and Gynecologic Oncology.

In The Last Decade

Hongzan Ji

9 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongzan Ji China 7 154 141 117 95 94 9 420
Ivo Marchetti Italy 12 161 1.0× 46 0.3× 125 1.1× 115 1.2× 113 1.2× 20 522
Ornella Carminati Italy 8 329 2.1× 149 1.1× 56 0.5× 82 0.9× 64 0.7× 13 445
Alexander Henke Germany 7 83 0.5× 159 1.1× 130 1.1× 17 0.2× 42 0.4× 9 393
Alexandra M. Santos Portugal 12 201 1.3× 71 0.5× 138 1.2× 45 0.5× 166 1.8× 12 385
Mark A. Glaire United Kingdom 10 320 2.1× 153 1.1× 152 1.3× 50 0.5× 37 0.4× 15 593
Amar Bhatnagar India 11 88 0.6× 73 0.5× 167 1.4× 60 0.6× 17 0.2× 23 359
Andrew Fischer United States 7 71 0.5× 75 0.5× 133 1.1× 20 0.2× 87 0.9× 10 346
Koichi Higaki Japan 8 109 0.7× 48 0.3× 152 1.3× 118 1.2× 49 0.5× 9 366
Núria Baixeras Spain 11 111 0.7× 63 0.4× 111 0.9× 28 0.3× 71 0.8× 24 326
Catherine Grande United States 6 140 0.9× 151 1.1× 196 1.7× 70 0.7× 14 0.1× 8 384

Countries citing papers authored by Hongzan Ji

Since Specialization
Citations

This map shows the geographic impact of Hongzan Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongzan Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongzan Ji more than expected).

Fields of papers citing papers by Hongzan Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongzan Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongzan Ji. The network helps show where Hongzan Ji may publish in the future.

Co-authorship network of co-authors of Hongzan Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Hongzan Ji. A scholar is included among the top collaborators of Hongzan Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongzan Ji. Hongzan Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Cao, Pengbo, Aiqing Yang, Peiyao Li, et al.. (2021). Genomic gain of RRS1 promotes hepatocellular carcinoma through reducing the RPL11-MDM2-p53 signaling. Science Advances. 7(35). 22 indexed citations
2.
Ji, Hongzan, et al.. (2015). Helicobacter pyloriinfection and inflammatory bowel disease in Asians: A meta-analysis. World Journal of Gastroenterology. 21(15). 4750–4756. 54 indexed citations
3.
Wu, Xiaowei, et al.. (2015). [Treating irritable bowel syndrome by wuling capsule combined pinaverium bromide: a clinical research].. PubMed. 35(4). 415–8. 2 indexed citations
4.
Wu, Xiaowei, et al.. (2014). Meta-analysis of ciprofloxacin in treatment of Crohn's disease. Biomedical Reports. 3(1). 70–74. 18 indexed citations
5.
Lü, Lei, Xiaobing Xu, Bin Zhang, et al.. (2014). Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs. Journal of Translational Medicine. 12(1). 36–36. 143 indexed citations
6.
Ji, Hongzan, et al.. (2013). Increased expression of chymase in inflammatory polyps in elderly patients with functional bowel disorder. Experimental and Therapeutic Medicine. 7(2). 371–374. 2 indexed citations
7.
Wang, Yucai, Zhenghong Yu, Chang Liu, et al.. (2008). Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. World Journal of Gastroenterology. 14(19). 3074–3074. 71 indexed citations
8.
Xie, Huahong, Jiugang Song, Kaige Liu, et al.. (2008). The Expression of Hypoxia-Inducible Factor-1α in Hepatitis B Virus-Related Hepatocellular Carcinoma: Correlation with Patients’ Prognosis and Hepatitis B Virus X Protein. Digestive Diseases and Sciences. 53(12). 3225–3233. 43 indexed citations
9.
Anttila, Maarit, Stina Syrjänen, Hongzan Ji, Seppo Saarikoski, & Karí Syrjänen. (1999). Failure to Demonstrate Human Papillomavirus DNA in Epithelial Ovarian Cancer by General Primer PCR. Gynecologic Oncology. 72(3). 337–341. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026